Structural basis of the drug-binding specificity of human serum albumin

Journal of Molecular Biology

Volumn 353, Issue 1, 2005, Pages 38-52

  Ghuman, Jamie ^a   Zunszain, Patricia A ^a   Petitpas, Isabelle ^a   Bhattacharya, Ananyo A ^a   Otagiri, Masaki ^b   Curry, Stephen ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Drug binding; Drug specificity; Human serum albumin; Protein crystallography

Indexed keywords

3 (3 CARBOXY 4 METHYL 5 PROPYL 2 FURYL)PROPIONIC ACID; 3,5 DIIODOSALICYLIC ACID; ADIPIODONE; AZAPROPAZONE; DIAZEPAM; DIFLUNISAL; IBUPROFEN; INDICAN; INDOMETACIN; OXYPHENBUTAZONE; PHENYLBUTAZONE; SERUM ALBUMIN; UNCLASSIFIED DRUG; WARFARIN;

ADSORPTION; ARTICLE; BINDING AFFINITY; CRYSTALLOGRAPHY; DRUG BINDING; MOLECULAR DYNAMICS; POLARIZATION; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 25144505772     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2005.07.075     Document Type: Article

References (56)

1. J. Hodgson ADMET - turning chemicals into drugs Nature Biotechnol. 19 2001 722 726
2. T. Peters All About Albumin: Biochemistry, Genetics and Medical Applications 1995 Academic Press San Diego
3. S. Curry, H. Mandelkow, P. Brick, and N. Franks Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites Nature Struct. Biol. 5 1998 827 835
4. A.A. Bhattacharya, T. Grüne, and S. Curry Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin J. Mol. Biol. 303 2000 721 732
5. I. Petitpas, T. Grüne, A.A. Bhattacharya, and S. Curry Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids J. Mol. Biol. 314 2001 955 960
6. I. Petitpas, C.E. Petersen, C.E. Ha, A.A. Bhattacharya, P.A. Zunszain, and J. Ghuman Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia Proc. Natl Acad. Sci. USA 100 2003 6440 6445
7. P.A. Zunszain, J. Ghuman, T. Komatsu, E. Tsuchida, and S. Curry Crystal structural analysis of human serum albumin complexed with hemin and fatty acid BMC Struct. Biol. 3 2003 6
8. M. Wardell, Z. Wang, J.X. Ho, J. Robert, F. Ruker, J. Ruble, and D.C. Carter The atomic structure of human methemalbumin at 1.9 Å Biochem. Biophys. Res. Commun. 291 2002 813 819
9. G. Sudlow, D.J. Birkett, and D.N. Wade The characterization of two specific drug binding sites on human serum albumin Mol. Pharmacol. 11 1975 824 832
10. X.M. He, and D.C. Carter Atomic structure and chemistry of human serum albumin Nature 358 1992 209 215
11. F. Herve, S. Urien, E. Albengres, J.C. Duche, and J.P. Tillement Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding Clin. Pharmacokinet. 26 1994 44 58
12. N.A. Kratochwil, W. Huber, F. Muller, M. Kansy, and P.R. Gerber Predicting plasma protein binding of drugs: a new approach Biochem. Pharmacol. 64 2002 1355
13. K. Valko, S. Nunhuck, C. Bevan, M.H. Abraham, and D.P. Reynolds Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity J. Pharm. Sci. 92 2003 2236 2248
14. G. Colmenarejo In silico prediction of drug-binding strengths to human serum albumin Med. Res. Rev. 23 2003 275 301
15. I. Petitpas, A.A. Bhattacharya, S. Twine, M. East, and S. Curry Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I J. Biol. Chem. 276 2001 22804 22809
16. A.A. Bhattacharya, S. Curry, and N.P. Franks Binding of the general anesthetics propofol and halothane to human serum albumin: high-resolution crystal structures J. Biol. Chem. 275 2000 38731 38738
17. H. Mao, P.J. Hajduk, R. Craig, R. Bell, T. Borre, and S.W. Fesik Rational design of diflunisal analogues with reduced affinity for human serum albumin J. Am. Chem. Soc. 123 2001 10429 10435
18. K.J. Fehske, U. Schläfer, U. Wollert, and W.E. Müller Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone Mol. Pharmacol. 21 1981 387 393
19. U. Kragh-Hansen Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin and other ligands Mol. Pharmacol. 34 1988 160 171
20. K. Yamasaki, T. Maruyama, U. Kragh-Hansen, and M. Otagiri Characterization of site I on human serum albumin: concept about the structure of a drug binding site Biochim. Biophys. Acta 1295 1996 147 157
21. P.J. Hajduk, R. Mendoza, A.M. Petros, J.R. Huth, M. Bures, S.W. Fesik, and Y.C. Martin Ligand binding to domain-3 of human serum albumin: a chemometric analysis J. Comput. Aided Mol. Des. 17 2003 93 102
22. C. Bertucci, A. Canepa, G.A. Ascoli, L.F. Guimaraes, and G. Felix Site I on human albumin: differences in the binding of (R)- and (S)-warfarin Chirality 11 1999 675 679
23. F. Beaudry, M. Coutu, and N.K. Brown Determination of drug-plasma protein binding using human serum albumin chromatographic column and multiple linear regression model Biomed. Chromatog. 13 1999 401 406
24. R.L. Rich, Y.S. Day, T.A. Morton, and D.G. Myszka High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE Anal. Biochem. 296 2001 197 207
25. L. Buchholz, C.H. Cai, L. Andress, A. Cleton, J. Brodfuehrer, and L. Cohen Evaluation of the human serum albumin column as a discovery screening tool for plasma protein binding Eur. J. Pharm. Sci. 15 2002 209 215
26. G. Colmenarejo, A. Alvarez-Pedraglio, and J.L. Lavandera Cheminformatic models to predict binding affinities to human serum albumin J. Med. Chem. 44 2001 4370 4378
27. R.D. Saiakhov, L.R. Stefan, and G. Klopman Multiple computer-automated structure evaluation model of the plasma protein binding affinity of diverse drugs Perspectives Drug Disc. Des. 19 2000 133 155
28. G. Sudlow, D.J. Birkett, and D.N. Wade Further characterization of specific drug binding sites on human serum albumin Mol. Pharmacol. 12 1976 1052 1061
29. I. Fitos, J. Visy, M. Simonyi, and J. Hermansson Stereoselective allosteric binding interaction on human serum albumin between ibuprofen and lorazepam acetate Chirality 11 1999 115 120
30. J. Chen, and D.S. Hage Quantitative analysis of allosteric drug-protein binding by biointeraction chromatography Nature Biotechnol. 22 2004 1445 1448
31. D.J. Birkett, S.P. Myers, and G. Sudlow Effects of fatty acids on two specific drug binding sites on human serum albumin Mol. Pharmacol. 13 1977 987 992
32. H. Vorum, and B. Honoré Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy J. Pharm. Pharmacol. 48 1996 870 875
33. R. Ivarsen, and R. Brodersen Displacement of bilirubin from adult and newborn serum albumin by a drug and fatty acid Dev. Pharmacol. Ther. 12 1989 19 29
34. 13C nuclear magnetic resonance study J. Clin. Invest. 87 1991 1431 1441
35. S.J. Henderson, and W.E. Lindup Interaction of 3-carboxy-4-methyl-5- propyl-2-furanpropanoic acid, an inhibitor of plasma protein binding in uraemia, with human albumin Biochem. Pharmacol. 40 1990 2543 2548
36. Y. Tsutsumi, T. Maruyama, A. Takadate, M. Goto, H. Matsunaga, and M. Otagiri Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin Pharm. Res. 16 1999 916 923
37. T. Sakai, K. Yamasaki, T. Sako, U. Kragh-Hansen, A. Suenaga, and M. Otagiri Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin Pharm. Res. 18 2001 520 524
38. M.H. Abraham, A. Ibrahim, A.M. Zissimos, Y.H. Zhao, J. Comer, and D.P. Reynolds Application of hydrogen bonding calculations in property based drug design Drug Discov. Today 7 2002 1056 1063
39. I. Sjoholm, B. Ekman, A. Kober, I. Ljungstedt-Pahlman, B. Seiving, and T. Sjodin Binding of drugs to human serum albumin: XI. The specificity of three binding sites as studied with albumin immobilized in microparticles Mol. Pharmacol. 16 1979 767 777
40. U. Kragh-Hansen Relations between high-affinity binding sites of markers for binding regions on human serum albumin Biochem. J. 225 1985 629 638
41. T. Sakai, A. Takadate, and M. Otagiri Characterization of binding site of uremic toxins on human serum albumin Biol. Pharm. Bull. 18 1995 1755 1761
42. B. Loun, and D.S. Hage Chiral separation mechanisms in protein-based HPLC columns. 1. Thermodynamic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin Anal. Chem. 66 1994 3814 3822
43. A. Saifer, and L. Goldman The free fatty acids bound to human serum albumin J. Lipid Res. 2 1961 268 270
44. S. Curry, P. Brick, and N.P. Franks Fatty acid binding to human serum albumin: new insights from crystallographic studies Biochim. Biophys. Acta 1441 1999 131 140
45. M.A. Schumacher, and R.G. Brennan Deciphering the molecular basis of multidrug recognition: crystal structures of the Staphylococcus aureus multidrug binding transcription regulator QacR Res. Microbiol. 154 2003 69 77
46. M. Sogami, and J.F. Foster Isomerization reactions of charcoal-defatted bovine plasma albumin. The N-F transition and acid expansion Biochemistry 7 1968 2172 2182
47. D.C. Carter, B. Chang, J.X. Ho, K. Keeling, and Z. Krishnasami Preliminary crystallographic studies of four crystal forms of serum albumin Eur. J. Biochem. 226 1994 1049 1052
48. E.A. Stura, and I.A. Wilson Analytical and production seeding techniques Methods 1 1990 38 49
49. Collaborative Computer Project No. 4 The CCP4 suite: programs for protein crystallography Acta Crystallog. sect. D 50 1994 760 763
50. A.T. Brünger, P.D. Adams, G.M. Clore, W.L. DeLano, P. Gros, and R.W. Grosse-Kunstleve Crystallography & NMR system: a new software suite for macromolecular structure determination Acta Crystallog. sect. D 54 1998 905 921
51. T.A. Jones, J.Y. Zou, S.W. Cowan, and M. Kjeldgaard Improved methods for building protein models in electron density maps and the location of errors in these maps Acta Crystallog. sect. A 47 1991 110 119
52. D.A. Fletcher, R.F. McMeeking, and D. Parkin The United Kingdom Chemical Database Service J. Chem. Inf. Comput. Sci. 36 1996 746 749
53. G.J. Kleywegt, K. Henrick, E.J. Dodson, and D.M. van Aalten Pound-wise but penny-foolish: how well do micromolecules fare in macromolecular refinement? Structure (Camb) 11 2003 1051 1059
54. D.M. van Aalten, R. Bywater, J.B. Findlay, M. Hendlich, R.W. Hooft, and G. Vriend PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules J. Comput. Aided Mol. Des. 10 1996 255 262
55. W.L. Delano The PyMOL Molecular Graphics System 2002 DeLano Scientific San Carlos, CA, USA
56. G.P. Brady, and P.F.W. Stouten Fast prediction and visualization of protein binding pockets with PASS J. Comput. Aided Mol. Des. 14 2000 383 401